A carregar...

Onset of secondary progressive MS after long‐term rituximab therapy – a case report

A patient with relapsing multiple sclerosis (RMS) was treated with a standard immunomodulatory therapy, but due to ongoing disease activity was switched to rituximab. Relapses ceased, but secondary progressive MS (SPMS) eventually appeared, associated with new focal spinal cord white matter lesions....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Main Authors: von Büdingen, H.‐Christian, Bischof, Antje, Eggers, Erica L., Wang, Shengzhi, Bevan, Carolyn J., Cree, Bruce A. C., Henry, Roland G., Hauser, Stephen L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5221476/
https://ncbi.nlm.nih.gov/pubmed/28078314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.377
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!